Growing epidemic of coronary heart disease in low- and middle-income countries

Insights

Coronary heart disease (CHD) is a major global cause of death, particularly impacting low- and middle-income nations. Addressing lifestyle factors and improving healthcare resources are key to managing this growing cardiovascular disease burden.

Area of Science:

  • Cardiology
  • Public Health
  • Epidemiology

Background:

  • Coronary heart disease (CHD) is the leading cause of mortality in developed nations and a significant contributor to the global disease burden.
  • In 2001, CHD caused 7.3 million worldwide deaths, with a disproportionate three-fourths occurring in low- and middle-income countries.
  • The increasing CHD burden in these regions is linked to socioeconomic shifts, increased longevity, and the adoption of lifestyle-related risk factors.

Purpose of the Study:

  • To analyze the global burden and varying impact of Coronary Heart Disease (CHD).
  • To identify factors contributing to the rise of CHD in developing countries.
  • To highlight the need for effective management strategies for the economic and health challenges posed by CHD.

Main Methods:

  • This study is based on a review of global mortality data and epidemiological trends related to Coronary Heart Disease (CHD).
  • Analysis of factors influencing CHD incidence, prevalence, and mortality rates across different countries.
  • Examination of the economic implications and potential solutions for managing CHD.

Main Results:

  • Coronary heart disease (CHD) represents the primary cause of death globally, especially in developing countries.
  • Significant variations in CHD incidence, prevalence, and mortality exist across developing nations.
  • Socioeconomic changes, increased lifespan, and lifestyle risk factors are driving the rise in CHD burden.

Conclusions:

  • The varying rates of CHD reflect differences in risk factors, competing causes of death, healthcare resource availability, and epidemiologic transition stages.
  • Despite its substantial economic impact, effective solutions are available to manage the growing burden of Coronary Heart Disease (CHD).
  • Urgent attention and targeted interventions are required to mitigate the escalating global impact of CHD.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...